Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nordstjernan is a Swedish family-controlled investment company that focuses on long-term value creation through active ownership of high-quality companies. Founded in 1890 and owned by the Axel and Margaret Ax:son Johnson Foundation, the firm operates with a perpetual investment horizon, allowing for sustainable business development. Nordstjernan maintains a dedicated investment focus on the healthcare and life sciences sectors, managing a portfolio that includes significant holdings in medical technology, diagnostics, and healthcare services. Key portfolio companies in this space include Etac, a provider of mobility equipment, and major stakes in publicly traded firms like AddLife and Mentice. The company provides strategic capital and industrial expertise to help its holdings achieve market-leading positions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nordstjernan.